Frontiers in drug delivery

· 1 paper in corpus
2024
doi:10.3389/fddev.2024.1339936 ·PMID:40836974

Ovarian cancers are a complex and heterogenic group of malignancies that are difficult to detect, diagnose and treat. Fortunately, considerable knowledge of ovarian cancer specific biomarkers has been generated, that is pertinent to the dev…